Resonance Specialties Limited
BSE: RESONANCE · Specialty Chemicals
Limited coverage
We are not actively covering this company or have limited coverage today. Click to request coverage.
Snapshot
Unlock Resonance Specialties Limited's vital signs
Growth · Profitability · Valuation · Strength · Conviction
Company Overview
Business
Resonance Specialties Limited is an Indian chemical manufacturer specialising in the production of Pyridines, Picolines, and Cyanopyridines. The company operates a vertically integrated facility in Tarapur, serving the pharmaceutical, agrochemical, and animal nutrition industries.
Business Model
The company generates revenue through the synthesis and sale of specialty chemical intermediates and vitamin B3 derivatives. It leverages its technical expertise in complex chemical synthesis to supply global life sciences corporations.
Growth Outlook
Growth is driven by the company's established role as a supplier to major global life sciences corporations and its focus on essential vitamin B3 components. Continued demand in the pharmaceutical and agrochemical sectors supports its long-term market positioning.
Key Risks
- Raw Material Price Volatility. Fluctuations in the cost of key chemical feedstocks can significantly impact profit margins.
- Regulatory Compliance. The chemical manufacturing sector is subject to stringent environmental and safety regulations that may necessitate ongoing capital expenditure.
- Geopolitical and Export Risks. As an exporter, the company is exposed to international trade barriers, currency fluctuations, and global supply chain disruptions.
- Concentration Risk. Reliance on specific chemical segments like Pyridines may leave the company vulnerable to shifts in demand within the pharmaceutical and agrochemical industries.
Start your research today
Unlock AI insights, financials, peers and live data on Resonance Specialties Limited and 5,000+ companies — free.
Key Metrics
REVENUE
₹90 Cr
TTM · standalone
NET PROFIT
₹10 Cr
TTM · standalone
EPS
₹9.01
TTM · standalone
RETURN ON EQUITY
15.7%
TTM · standalone
RETURN ON CAPITAL EMPLOYED
20.5%
TTM · standalone
P/E
14.6x
Q4 FY26 · standalone
EV/EBITDA
6.7x
Q4 FY26 · standalone
EBITDA MARGIN
17.3%
TTM · standalone
NET PROFIT MARGIN
18.8%
Q4 FY26 · standalone
DEBT TO EQUITY
0.0x
Q4 FY26 · standalone
Peers · Specialty Chemicals
| Company | Mkt Cap | P/E | EV/EBITDA | Rev Gr YoY | EBITDA Mgn | ROE | ROCE | 1Y Return |
|---|---|---|---|---|---|---|---|---|
Resonance Specialties LimitedRESONANCE | ₹188 Cr | 18.10 | 12.15 | 16.0% | 17.3% | 15.7% | 20.5% | +61.0% |
Kronox Lab Sciences LimitedKRONOX | ₹666 Cr | 23.05 | 16.30 | 6.1% | 38.7% | 27.7% | 35.9% | +11.2% |
Black Rose IndusBLACKROSE | ₹584 Cr | 26.01 | 16.40 | — | 11.0% | 13.9% | 18.9% | +19.1% |
Vipul OrganicsVIPULORG | ₹506 Cr | 63.11 | 30.62 | 7.7% | 10.4% | 8.9% | 13.4% | +29.6% |
Plastiblends India LimitedPLASTIBLEN | ₹493 Cr | 11.54 | 6.83 | 5.5% | 9.2% | 9.7% | 12.8% | +0.5% |
Aarti SurfactantAARTISURF | ₹458 Cr | 24.91 | 9.80 | 25.2% | 6.1% | 7.7% | 12.4% | +19.0% |
As of Q4 FY26
Financials
Resonance Specialties Limited
BSE: RESONANCE · Specialty Chemicals
Limited coverage
We are not actively covering this company or have limited coverage today. Click to request coverage.
Snapshot
Unlock Resonance Specialties Limited's vital signs
Growth · Profitability · Valuation · Strength · Conviction
Company Overview
Business
Resonance Specialties Limited is an Indian chemical manufacturer specialising in the production of Pyridines, Picolines, and Cyanopyridines. The company operates a vertically integrated facility in Tarapur, serving the pharmaceutical, agrochemical, and animal nutrition industries.
Business Model
The company generates revenue through the synthesis and sale of specialty chemical intermediates and vitamin B3 derivatives. It leverages its technical expertise in complex chemical synthesis to supply global life sciences corporations.
Growth Outlook
Growth is driven by the company's established role as a supplier to major global life sciences corporations and its focus on essential vitamin B3 components. Continued demand in the pharmaceutical and agrochemical sectors supports its long-term market positioning.
Key Risks
- Raw Material Price Volatility. Fluctuations in the cost of key chemical feedstocks can significantly impact profit margins.
- Regulatory Compliance. The chemical manufacturing sector is subject to stringent environmental and safety regulations that may necessitate ongoing capital expenditure.
- Geopolitical and Export Risks. As an exporter, the company is exposed to international trade barriers, currency fluctuations, and global supply chain disruptions.
- Concentration Risk. Reliance on specific chemical segments like Pyridines may leave the company vulnerable to shifts in demand within the pharmaceutical and agrochemical industries.
Start your research today
Unlock AI insights, financials, peers and live data on Resonance Specialties Limited and 5,000+ companies — free.
Key Metrics
REVENUE
₹90 Cr
TTM · standalone
NET PROFIT
₹10 Cr
TTM · standalone
EPS
₹9.01
TTM · standalone
RETURN ON EQUITY
15.7%
TTM · standalone
RETURN ON CAPITAL EMPLOYED
20.5%
TTM · standalone
P/E
14.6x
Q4 FY26 · standalone
EV/EBITDA
6.7x
Q4 FY26 · standalone
EBITDA MARGIN
17.3%
TTM · standalone
NET PROFIT MARGIN
18.8%
Q4 FY26 · standalone
DEBT TO EQUITY
0.0x
Q4 FY26 · standalone
Peers · Specialty Chemicals
As of Q4 FY26